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1. Introduction
  Cirrhosis is a complex pathological process. In clinic, the 
only effective treatment method is liver transplantation, but 
restricted by the donor, surgery costs, limited cure rate and 
other factors. Recent studies suggest that bone marrow-
derived mesenchymal stem cells (MSCs) as a member of 
adult stem cells may regulate the liver function of the 
liver failure animal. MSCs have lots of advantages such as 
easy obtainment, strong copy and proliferative capacity, 
and mature culture in vitro technology[1]. Rougan Huaqian 
granules are a new prescription which is a combination 
of the treatment of prominent TCM doctors on hepatitis 
cirrhosis. It has a good liver protection and anti-hepatic 
fibrosis effects[2]. However, its mechanism is still not clear.
In this study, we transplanted the Rougan Huaqian granules 
combined with human MSCs (hMSCs) into the carbon 
tetrachloride-induced liver cirrhosis rats and observed 
the survival rate, liver function, hepatic stellate cells (HSC) 
activation and pathological changes after this treatment.
2. Materials and methods
2.1. Rats
  Sixty healthy SPF grade SD rats (male or female) weighing 
160-200 g were selected. All animals were provided by 
the Experimental Animal Center of Guangxi Province and 
housed in the SPF animal room (n=5) with autoclaved water 
for free drink, a constant temperature of 25 °C, and constant 
humidity of 40%-50%.
Objective: To observe the effect of Rougan Huaqian granules combined with human 
mesenchymal stem cell (hMSC) transplantation on the liver fibrosis in carbon tetrachloride-
induced cirrhosis rats. Methods: Sixty SD rats were randomly divided into five groups. The rats 
in control group received intraperitoneal injection of saline, while those in model control group, 
treatment group A, group B and group C received intraperitoneal injection of carbon tetrachloride 
oily solution to induce liver cirrhosis within 8 weeks. Then, the rats in the model control group, 
treatment group A, treatment group B, treatment group C received vein tail injection of saline, 
Rougan Huaqian granules, hMSC suspension and Rougan Huaqian granules combined with 
hMSC suspension. Results: The treatment groups had significantly different liver function (AST 
levels), liver fibrosis index (laminin and HA), hepatic sinusoidal walls毩-smooth muscle actin, 
桇 collagen  and laminin protein expression and 栺, 栿 collagen from the model group (P<0.05). 
The transplanted cells showed human hepatocyte-like cells differentiation trend in the liver. 
Conclusions: The Rougan Huaqian granules combined with hMSC transplantation can alleviate 
liver fibrosis in cirrhosis rats.
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2.2. Reagents and instruments
  An incubator was purchased from Eppendorf company, 
Germany. An inverted microscope was purchased from 
Nikon company, Japan. FACS was purchased from BD 
Biosciences. Rabbit anti-mouse毩-smooth muscle actin (毩
-SMA) monoclonal antibody, 桇 collagen (Col 桇) monoclonal 
antibody, rabbit anti-mouse laminin (LN) monoclonal 
antibody, and anti-mouse CD29, CD34, CD44, CD45, CD105, 
CD133, CD147 monoclonal antibody were purchased from 
American Biolegend company. RT-PCR kits were purchased 
from Bioasis Biological Technology Co., Ltd. Collagen type 
栺 (Col 栺), collagen type 栿 (Col 栿), MMP-13 and 毬-actin 
were purchased from Wuhan Boster biotechnology company. 
CCl4 was purchased from Jiangsu Hengrui Corporation, ALT 
reagents from the American Dream Company, and fetal 
bovine serum from Invitrogen Corporation. The Rougan 
Huaqian granules were composed of were composed of 
astragalus 45 g, oysters 30 g, polygonatum 20 g, medlar 
20 g, coix seed 45 g, orange 10 g, hiraute shiny bugleweed 
herb 30 g, galli stomachichum corium 15 g, turtle shell 30 g, 
polygonum cuspidate 20 g, cortex moutan 12 g, and jujube 
15 g.
2.3. In vitro culture of hMSCs 
  Umbilical cord blood were immediately collected from 
newborns after delivery under sterile conditions. Cord 
blood monocytes were isolated with lymphocyte separating 
medium and inoculated on culture dish. The conditions 
are DMEM (Dulbecco’s Modified Eagle’s Medium) culture 
medium containing 10% (v/v) fetal bovine serum at 37 °C 
with saturation humidity in 5% (v/v) CO2. The medium was 
changed after 2 d. When cell confluence was 80%, the cells 
were sub-cultured by proportion 1:3 with the digestion of 
0.25% trypsin and 0.02% EDTA.
2.4. Determination of cell phenotype
  A proper amount of the 5th generation of human umbilical 
cord blood (hUCB) MSCs were made into single cell 
suspension and added the anti-human CD29, CD34, CD44, 
CD45, CD105, CD133, CD147 monoclonal antibody, followed 
by incubation at 4 °C for 30 min to determine cell phenotype 
by flow cytometry .
2.5. Experimental animal model and grouping method
 
  Sixty SD rats were randomly divided into control group, 
model group, treatment group A, treatment group B and 
treatment group C (n=12). The control group received 
intraperitoneal injection of saline 3 mL/kg, 2 times a week 
for 8 weeks. Four rats were sacrificed and the blood and 
liver tissue were collected for liver function test and HE 
staining, respectively. The model control group received 
intraperitoneal injection 50% volume fraction of carbon 
tetrachloride oily solution 3 mL/kg, 2 times a week for 8 
weeks. Four rats were sacrificed and the blood was obtained 
for liver function test. Their liver tissues were used for 
HE staining and immunohistochemical staining. After the 
injection of carbon tetrachloride olive oil for 8 weeks, the 
rats filled 10 mL/kg saline into the stomach also received 
0.2 mL vein tail injection of saline once a day for 4 weeks. 
Before 8 weeks, the method of treatment group, treatment 
group B and treatment group C was the same as that of the 
model group. After 4 weeks, the rats in the treatment group 
A were filled Rougan Huaqian granules into the stomach 
(concentration of 5 g/kg) and received vein tail injection of 
0.2 mL saline once a day. The rats in the treatment group B 
were filled 10 mL/kg saline into the stomach and received 
vein tail injection of 1×106 hMSCs once a day. The rats in the 
treatment group C were filled Rougan Huaqian granules into 
the stomach (concentration of 5 g/kg) and received vein tail 
injection of 1×106 hMSCs once a day. Finally, all rats were 
sacrificed.
2.6. Serological examination
  Rats were anesthetized and subjected to thoracotomy. 
The blood from inferior vena cava was added 0.3% heparin 
sodium anticoagulant. Then 1 mL of blood  was centrifuged 
and used to determine the levels of AST, ALT and hepatic 
fibrosis indexes.
2.7. Histological observation
  Rats were anesthetized and subjected to thoracotomy. The 
liver tissue was collected at hepatic hila for HE staining, 
and the histological features were observed. Sinusoidal walls 
paraffin sections were dewaxed, using immunohistochemical 
EnVision method. Rabbit anti-rat毩-SMA monoclonal 
antibody (working concentration 1:100), Col 桇 monoclonal 
antibodies (working concentration 1:100), LN monoclonal 
antibody (working concentration 1:100) and ready-to-use 
secondary antibody were used for staining in accordance 
with instructions. PBS instead of primary antibody was used 
as a negative control.
2.8. RT-PCR detection of Col 栺, Col 栿, and MMP-13 
mRNA expression
  Partial liver tissue was immediately collected after surgical 
resection and stored in liquid nitrogen. Total RNA was 
extracted using Trizol method. The primers asre shown in 
Table 1. After agarose gel electrophoresis, the results were 
analyzd under DC2000 gel imaging analyzer.
  The gray integral value of each stripe was automatically 
read and recorded by the computer. Statistical analysis was 
conducted based on sample integral value/internal reference 
ratio. Results were determined by the double-blind method, 
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and three slice of each group were separately judged by two 
experienced pathologists. Five typical slice were selected 
and five different visual fields were observed under ×200 
magnification. Sinusoidal walls positive region of the 
standard measurement window area was determined.
2.9. Statistical analysis
  All  data are expressed as mean依SD. The data were 
analyzed by SPSS 13.0 statistics software. P<0.05 was 
considered statistically significant.
3. Results
3.1. Determination of hMSCs cell phenotype
  CD29, CD34, CD44, CD133 and CD147 were positive, while 
CD45 and CD105 were negative.
3.2. Changes of body weight and liver weight before and after 
the transplantion of hMSCs 
  The rats in the normal control group showed normal 
activities. The liver was purple-red with thin sharp edges 
and smooth surface. The body weight and liver weight are 
shown in Table 1. The rats in the model control group had 
poor mental status, less activity and decrease of food intake 
and weight. Compared with the normal group, the difference 
was statistically significant (P<0.05). Liver volume increased 
significantly than the normal liver, and the surface has 
multiple homogeneous nodes. The rats in treatment group 
A had poor mental status, less activity and decrease of food 
intake and weight. Compared with the normal group, the 
difference was statistically significant (P<0.05).
  The liver surface was relatively smooth with rare nodules. 
Compared with the normal group, the difference was not 
statistically significant. The rats in the treatment group B 
had normal spirit, activity, diet and normal weight. Liver 
volume was increased significantly compared with the 
normal liver, and the surface was relatively smooth with rare 
nodules. Compared with the normal group, the difference 
was not statistically significant. The rats in the treatment 
group C had normal spirit, activity, diet and normal weight.
Liver volume was increased significantly compared with the 
normal liver, and the surface was relatively smooth with rare 
nodules. Compared with the normal group, model control 
group, treatment group A, the differences were statistically 
significant (P<0.05). The body weight and liver weight 
changes are shown in Table 2.
3.3. Changes of serum index before and after the 
transplantion of hMSCs 
  The ALT, AST in the model control group and treatment 
group showed an increasing trend (Table 3). Compared with 
the normal group, the difference was statistically significant 
(P<0.05). The AST change in the treatment group C was lower 
than that in the model control group, and the differences 
were statistically significant (P<0.05). The HA changes of 
the model control group and the treatment group showed 
an increasing trend. Compared with the normal group, the 
differences were statistically significant (P<0.05). The LN 
and HA in the treatment group were lower than those in the 
control group, and the difference was statistically significant 
(P<0.05). The PC 栿 and CIV of four indicators of hepatic 
fibrosis did not change significantly in each group (Table 3).
3.4. Liver pathological changes
  HE staining of liver tissue sections showed that normal 
control group rats had normal structure of hepatic lobule 
and no inflammatory cell infiltration, and there was only a 
small amount of collagen fibers around the portal area and 
central vein. Rat lobules in the model control group were 
separated by hyperplasia of liver collagen fibers and formed 
the hepatic pseudolobule, which was obvious around the 
capsule, portal area and central vein. The collagen fibers 
hyperplasia in the treatment group A were significantly 
reduced, there was still a small amount of pseudolobule, 
and the collagen fibers were also significantly reduced. The 
collagen fibers hyperplasia in the treatment group B were 
significantly reduced, and there was still a small amount 
of pseudolobule, but the collagen fibers were around the 
capsule, portal area and central vein. There were many 
morphologically normal liver cells surrounding normal 
Table 1
Primer sequences for NF-k毬, MMP-2 and 毬-actin genes.
Primer name Primer sequences Fragment length (bp) Annealing temperature (曟)
Collagen type 栺 5'-cagacgggagtttctcctcggacgt-3' 730 58
5'- gaccaggaggaccaggaagtccacgt-3'
Collagen type 栿 5'-agtcttatcagccctgatggttc-3' 600 60
5'-gatcaggaccaccaatgtcatag-3'
MMP-2 5'-agatcttcttcttcaaggaccggtt-3' 225 63
5'-ggctggtcagtggcttggggta-3'
毬-actin 5'-ggcaagttcaacggcacag-3' 626 59
5'-cgccagtagactccacgacat-3’
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lobules. The collagen fibers hyperplasia in the treatment 
group C was significantly reduced, although there was still 
a small amount of pseudolobule. The collagen fibers around 
and in the lobules were significantly reduced, and there 
were many morphologically normal liver cells surrounding 
lobules. 
3.5. The毩-SMA, Col 桇 and LN protein expression in 
sinusoidal walls
  In the normal group, the rat liver毩-SMA-positive staining 
was limited to sinusoidal walls, Col 桇 mainly existed in 
the sinusoidal walls with continuous positive expression, 
and LN existed in sinusoidal walls with discontinuous 
positive expression. The毩-SMA positive expression was 
significantly increased in the model control group and the 
range was significantly expanded, and Col 桇, LN positive 
expression were significant. The毩-SMA, Col 桇 and LN 
positive degree in each treatment group was decreased at 
different levels (Table 4).
Table 4
Sinusoidal walls 毩-SMA, Col 桇 and LN positive area ratio. 
Group 毩-SMA Col 桇 LN
Normal control group  1依0 6依1 1依0
Model control group 10依2*  8依2*  7依1*
Treatment group A    6依2*#  8依2*  5依1*
Treatment group B    5依1*#  8依2*   3依1*#
Treatment group C    4依1*#   7依1*#     2依1*#†
*P<0.05 vs. the normal control group; #P<0.05 vs. the model control 
group; †P<0.05 vs. the treatment group A. 
3.6. Relative expression levels of Col I, Col 栿 and MMP-2 
mRNA in liver tissue
  All samples were analyzed by RT-PCR, and the semi-
quantitative results showed the Col 栺, Col 栿 and MMP-2 
expression in the model control group were significantly 
higher than that in the normal control group. The Col 栺 
and Col 栿 in the treatment group A, treatment group B and 
treatment group C were significantly lower than those in the 
model control group, and the difference was statistically 
significant (P<0.05) (Table 5).
Table 5
Expression levels of Col 栺, Col 栿 and MMP-2 mRNA.
Group Col 栺  Col 栿 MMP-2
Normal control group 0.2依0.1 0.6依0.1 0.4依0.2
Model control group  1.6依0.8*  1.3依0.2*  0.6依0.3*
Treatment group A   1.2依0.5*#   1.1依0.2*#  0.6依0.2*
Treatment group B   1.1依0.4*#   1.2依0.2*#  0.5依0.2*
Treatment group C      0.7依0.2*#†‡   1.0依0.2
*#  0.5依0.1*
*P<0.05 vs. the normal control group; #P<0.05 vs. the model control 
group; †P<0.05 vs. the treatment group A; ‡P<0.05 vs. the treatment 
group B. 
4. Discussion
  Cirrhosis is an irreversible and incurable disease. Liver 
transplantation is an effective method for cirrhosis treatment, 
but the shortage of donor, high cost and other factors have 
limited the promotion of this method. In recent years, stem 
cell transplantation as a new treatment for cirrhosis attracts 
more and more attention[3]. Rougan Huaqian granules 
mainly treat liver fibrosis by invigorating spleen and kidney, 
nourishing Yin and nourishing liver, strengthening body 
resistance and eliminating dampness[4-6].
  HMSCs can differentiate into various types of terminal 
potential mature cells, which have lots of advantages such as 
higher ability to differentiate, easy amplification in vitro and 
lower rejection reactions[7,8]. Related studies suggest that 
the protein expression can still be detected after 6 weeks of 
Table 2
Body weight and liver weight changes before and after the transplantation.
Group Body weight (g) Liver weight (g)
Normal control group 388依34  97依11
Model control group   322依29* 178依24*
Treatment group A   332依29* 112依15#
Treatment group B   359依28#    198依22*#†
Treatment group C     362依30#†    216依25*#†
 *P<0.05 vs. the normal control group; #P<0.05 vs. the model control group; †P<0.05 vs. the treatment group A.
Table 3
Serum index changes of rats.  
Group ALT (IU/mL) AST (IU/mL) LN HA PC 栿 CIV
Normal control group 41依3 120依10  94依17 10依5 18依4 24依11
Model control group  92依7*  213依31* 132依34*  14依8* 16依4 28依14
Treatment group A  89依5*  195依30*  128依30*#  13依7* 16依3 28依13
Treatment group B  85依5*  200依32*  125依28*#  13依8* 15依3 28依14
Treatment group C  77依3*       178依35*#† ‡ 109依28
#  11依7# 15依3 28依14
*P<0.05 vs. the normal control group; #P<0.05 vs. the model control group; †P<0.05 vs. the treatment group A; ‡P<0.05 vs. the treatment group B.
 Zhen-Chang Wang et al./Asian Pacific Journal of Tropical Medicine (2014)576-581580
the transplantation of the umbilical cord blood cell in vitro[9-
11]. In this study, the determination of hMSCs cell phenotype 
showed CD29, CD34, CD44, CD133 and CD147 were positive, 
while CD45 and CD105 were negative, which was consistent 
with previous literature[12]. These results confirmed that 
these cells have characteristics of MSCs, which are primary 
stem cell. CCL4 as the main drug of cirrhosis is highly 
hepatotropic, and it can cause liver cell necrosis and 
proliferation of collagen fibers. Studies suggest that CCL4 can 
lead to cirrhosis and block liver repair[13].
  In this study, we injected hMSCs to cirrhotic rat model 
and observed the effect of MSCs on liver function. Carbon 
tetrachloride can cause liver cell degeneration and necrosis 
and promote collagen fiber proliferation.
  After 8 weeks, the study showed that rats had poor mental 
status, less activity and decrease of food intake and weight. 
Anatomy showed liver weight was significantly increased.
There were nodules over the liver surface, proliferation of 
a large number of collagen fibers and formation of pseudo-
lobules. Liver biopsy microscopic observation showed 
liver collagen fibers and inflammatory cells increased 
significantly, which was obvious around the capsule, 
portal area and central vein. After intraperitoneal injection 
of MSCs, the collagen fibers were significantly reduced, 
and there awere many morphologically normal liver cells 
surrounding lobules. 
  This study suggests that the body weight was significantly 
different between the model group and control group or 
between the model group and treatment group. The liver 
weight of the model control group and treatment group was 
significantly higher than that of the normal group, and the 
effect of Rougan Huaqian granules combined with hMSCs 
transplantation treatment was the best. The Rougan Huaqian 
granules combined with hMSCs transplantation treatment 
can resist hepatic fibrosis and promote cell regeneration.
The mechanism may due to the Rougan Huaqian granules 
can regulate the activin A signal transduction, inhibit 
inflammation and necrosis, resist hepatic fibrosis, secrete the 
activity factor which can promote hepatocyte proliferation, 
and accelerate liver tissue repairment[14]. The study showed 
that after CCL4 intraperitoneal injection, rats produced a lot 
collagen fibers, formed hepatic lobule, seriously affected 
liver function, and then gradually formed cirrhosis resulting 
in the descrease of liver. This result corresponds to the 
related studies. Therefore, this experiment showed CCL4 is 
effective to promote cirrhosis, and human MSCs is feasible 
and effective for promoting the autogenous repairment of the 
liver.
  Kassem et al showed that the hMSCs have a therapeutic 
potential for rat liver dysfunction, and its transplanted cells 
showed human liver-like cells differentiation trend in the 
tested liver[15]. HMSCs can not only improve the state of 
the liver function but also improve the survival rate of rats. 
Studies suggest that after 7 weeks, there were a large number 
of collagen fibers of the liver tissue of rats and pseudolobule 
was formed, but MSC transplantation can significantly 
reduce the secretion of collagen fibers in the liver tissue[16-
18]. The rat model liver function index and liver fibrosis 
indexes were detected, and the results showed that the ALT 
and AST of the treatment group were lower than those of 
the model group. The effect of Rougan Huaqian granules 
combined with hMSCs transplantation treatment had the best 
obvious effects. The LN and HA in the treatment group were 
significantly lower than those in the model control group, 
and the difference was statistically significant. The main 
mechanism of its occurrence may be the hMSCs injection has 
the human hepatocyte-like cells differentiating tendency 
and also improves the blood biochemical properties and 
histological structure of the liver tissue in the peripheral 
blood. Neonatal human hepatocyte-like cells can enhance 
the liver function of rats and improve the spirit, activity, 
diet and other clinical manifestations. Some studies show 
that it can improve liver fibrosis, maintenance therapy and 
eventually reverse the trend of cirrhosis[19-23].
  Therefore, hMSCs become the research direction for 
the improvement of liver cirrhosis.毩-SMA expression 
is the activation marker of HSCs. Immunohistochemical 
staining showed毩-SMA expression can significantly 
increased in liver fibrosis. After MSCs transplantation, the
毩-SMA expression can be significantly reduced, which is 
consistent with previous research results[24-27]. After MSCs 
transplantation, the毩-SMA, Col 桇 and LN protein levels 
were significantly reduced, and the Col 栺, Col 栿 and 
MMP-2 mRNA levels were decreased. The Col 栺 and Col 
栿 were decreased significantly. The Col 栺 reduced most 
obviously in the Rougan Huaqian granules combined with 
hMSCs transplantation group. HSCs are the key link of liver 
fibrosis, which has a greater ability to synthesize collagen. 
It can synthesize a lot of collagen fiber protein and lead to 
excessive accumulation of ECM in liver, eventually causing 
liver fibrosis and cirrhosis. These results indicate one of the 
inhibition mechanisms of bone marrow MSCs on the HSC 
proliferation may be it can down-regulate Col 栺 and Col 
栿 mRNA expression and Col 桇 and LN protein expression, 
which can inhibit HSC proliferation[28,29].
  In summary, the mechanism of hMSCs to promote self-
repair of liver parenchymal cells is still unclear and the 
interaction with the surrounding cells and related factors 
still needs further study. These methods are still in the 
laboratory stage, and the specific cost and therapeutic ratio 
and therapeutic endpoint still need to be further confirmed.
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